Back to Trades
Fisher Andrew
General CounselCIK 0002014301
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025
Fisher Andrew, General Counsel, has filed 3 SEC reports (2025), all concentrated in Verona Pharma plc (VRNA), totaling $5.1M in disclosed volume. Weighing $0 bought versus $126.0K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Oct 8 | VRNA Verona Pharma plc | Fisher Andrew | General Counsel | Exercise | $4.5M |
| Aug 5 | VRNA Verona Pharma plc | Fisher Andrew | General Counsel | Sell | $126.0K |
| Jul 9 | VRNA Verona Pharma plc | Fisher Andrew | General Counsel | Exercise | $451.5K |
3 filings